Lund University

Biotech

Cambridge, Lund University spinout Wren pens Eisai pact

U.K.-based alpha-synuclein biotech Wren will partner with Japanese pharma Eisai to seek out new ways of targeting neuro disorders.
Ben Adams Nov 30, 2020 8:53am

Alzheimer's blood tests show promise, giving decades of warning

Jul 28, 2020 2:08pm

Tamping down stroke damage with a drug that shields neurons

Jul 2, 2020 8:30am

Cell therapy restores mobility in rodent models of stroke

Apr 10, 2020 8:45am

Novo Nordisk owner puts up $43M to analyze proteins

Jan 25, 2018 10:40am

Targeting immune cells could treat diabetes and high blood pressure

Mar 17, 2017 9:08am